List of received applications (By symposium/topics code)

Top > Application > List of received applications (By symposium/topics code)


SY) SCEJ Division Symposium

SY-69. [Symposium of Division of Biochemical Engineering] Next Generation Bioseparation Process From Antibody Drug to Gene and Cell Therapy Vectors

Organizer(s): Yamamoto Shuichi (Yamaguchi Univ.)

New and efficient separation methods or separation media/devices are expected for downstream processes of antibody drugs and gene-cell therapy vectors. In this symposium, recent research developments in this field will be presented, and discussed.

Most recent update: 2024-06-27 04:04:01

The keywords that frequently used
in this topics code.		KeywordsNumber
AAV2
Cell Culture1

ACKN
No.		Title/Author(s)KeywordsStyle
15[Requested talk] Quantitative reproduction of virus filtration, virus removability and protein/virus retention within the membrane using an advanced multilayer membrane model
(Asahi Kasei Medical) (Reg)Shirataki Hironobu		Virus filter
virus reduction
multilayer model
O
62[Requested talk] Next Gen. Cell Culture: Perfusion, Scale-Up and Design Space
(MAB) Murakami Sei		Bioreactor
Cell Culture
Design Space
O
126Modeling of ultrafiltration and diafiltration using stagnant film theory for viral vector purification
(Merck) (Reg)Ito Takao		Ultrafiltration
viral vector
modeling
O
392Enhancing Productivity and Consistent Product Quality in Biopharmaceutical Production: Short Bed Height Strategies with Amsphere™ A3
(JSR) (Cor)Ryu Jung Wan		Protein A chromatography
Biologics
Protein purification
O
646[Requested talk] An accelerated method for determining flow-through chromatography conditions in hydrophobic interaction chromatography of proteins
(Tosoh) *(Cor)Wang Mengfan, (Cor)Hashimoto Yoshimi, (Cor)Ito Seiji, (Yamaguchi U.) (Reg)Yamamoto Shuichi		flow-through chromatography
hydrophobic interaction chromatography
model simulation
O
675[Requested talk] Implementation and Scale-Up of Continuous Chromatography for Biopharmaceuticals
(Takeda Pharmaceutical) *(Cor)Takeuchi Hirohisa, (Cor)Nonogawa Mitsuru, (Cor)Chuman Yasuo, (Cor)Hasegawa Sumiko, (Cor)Kaminagayoshi Takashi		Continuou Column Chromatograpy
Prurification Process
Biopharmaceuticals
O
933[Requested talk] DEVELOPMENT OF A NOVEL ANION-EXCHANGE MEDIUM THAT ENABLES RAPID AND LARGE-SCALE PURIFICATION OF NEW DRUG MODALITIES
(YMC) *(Cor)Takahashi Ryosuke, (Cor)Wada Ryota, (Cor)Sagami Takuya, (Cor)Sakoda Yumiko, (Cor)Miyake Mayu, (Cor)Osumi Yukiko, (Cor)Kaji Nanaka, (Cor)Nakajima Taeko		anion-exchange medium
new drug modalities
adeno-associated virus
O
1051Development of continuous downstream process for antibodies and its evaluation
(MAB/Yamaguchi U.) *(Cor)Konoike Fuminori, (Reg)Yamamoto Shuichi		Continuous downstream process
monoclonal antibody
Process efficiency
O
1056Separation of AAV particles by ion-exchange chromatography
(JNC) *(Cor)Toba Junya, (Cor)Matsumoto Yoshihiro		AAV
ion-exchange chromatography
O
1059[Invited lecture] Manufacturing process for AAV vectors used for gene therapy
(TAKARABIO) Sugimoto Akinori		AAV
gene therapy
vector
O
List of received applications (By topics code)
List of received applications
SCEJ 55th Autumn Meeting (Sapporo, 2024)

Organizing Committee of SCEJ 55th Autumn Meeting (2024)
Inquiry